The Sox Box Goes Gray in May to Support Brain Cancer Research

The Sox Box Goes Gray in May to Support Brain Cancer Research

By Jeremy Garber at 21 May 2018, 11:17 AM

The Sox Box Beast Mode Compression Sleeves

Beast Mode Compression Sleeves from the The Sox Box!

In honor of Brain Cancer Awareness Month, The Sox Box has teamed up with Gateway for Cancer Research to show cancer that it cannot hide!

The Sox Box is pledging 20% of all proceeds from the sale of its Beast Mode Compression Sleeves to support Gateway-funded brain cancer clinical trials that offer better treatment options to people fighting brain cancer TODAY!

These new compression sleeves are designed to both increase your energy while helping to improve circulation in the legs, keeps the tightest fit at the ankle with the pressure decreasing going up the leg. These socks are a wicking sock, infused with Moisture Management, made to keep your legs dry... perfect for getting in Beast Mode this Spring!

"The Sox Box has chosen to partner with Gateway for Cancer Research because we are impressed with Gateway's ability to provide 99 cents of every dollar to funding clinical trials that fight cancer. Athena (co-founder of SoxBox) lost her father to pancreatic cancer so Gateway’s work hits close to our lives and we know countless other friends and family members who are affected by different forms of cancer. It is an honor and privilege to be a part of the solution for such a serious health issue." –Vince Suich, Founder of The Sox Box

Give the hope of better treatment options to people with brain cancer - order your Beast Mode Compression Sleeves today!


0 comments posted

Post a comment

Make me anonymous

2 + 1 =

Solve this math problem and enter the result. E.g. for 1 + 3, enter 4.

You must provide a response to the reCaptcha challenge.



2020 2019 2018 2017 2016 2015
99 cents of every dollar received directly funds cancer clinical trials


Current Gateway-funded clinical trials


Clinical trials funded at leading institutions worldwide


Funds one patient for one day at a Gateway-funded clinical trial


Mission Partners